Coeptis Therapeutics Analyst Ratings
Coeptis Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/22/2023 | 219.15% | Ladenburg Thalmann | → $3 | Initiates Coverage On | → Buy |
| 05/25/2023 | 963.83% | EF Hutton | → $10 | Assumes | → Buy |
| 05/18/2023 | 538.3% | EF Hutton | → $6 | Reiterates | Buy → Buy |
| 05/10/2023 | 538.3% | EF Hutton | → $6 | Reiterates | → Buy |
| 04/19/2023 | 325.53% | JonesTrading | → $4 | Initiates Coverage On | → Buy |
| 04/05/2023 | 538.3% | EF Hutton | → $6 | Reiterates | → Buy |
| 03/29/2023 | 538.3% | EF Hutton | → $6 | Reiterates | → Buy |
| 12/13/2022 | 538.3% | EF Hutton | → $6 | Initiates Coverage On | → Buy |
| 12/12/2022 | 538.3% | EF Hutton | → $6 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 09/22/2023 | 219.15% | 拉登堡塔爾曼 | → 3 美元 | 啓動保障 | → 購買 |
| 2023 年 5 月 25 日 | 963.83% | EF Hutton | → 10 美元 | 假設 | → 購買 |
| 05/18/2023 | 538.3% | EF Hutton | → 6 美元 | 重申 | 購買 → 購買 |
| 05/10/2023 | 538.3% | EF Hutton | → 6 美元 | 重申 | → 購買 |
| 04/19/2023 | 325.53% | JonesTrading | → 4 美元 | 啓動保障 | → 購買 |
| 04/05/2023 | 538.3% | EF Hutton | → 6 美元 | 重申 | → 購買 |
| 03/29/2023 | 538.3% | EF Hutton | → 6 美元 | 重申 | → 購買 |
| 12/13/2022 | 538.3% | EF Hutton | → 6 美元 | 啓動保障 | → 購買 |
| 12/12/2022 | 538.3% | EF Hutton | → 6 美元 | 啓動保障 | → 購買 |
What is the target price for Coeptis Therapeutics (COEP)?
Coeptis Therapeutics（COEP）的目標價格是多少？
The latest price target for Coeptis Therapeutics (NASDAQ: COEP) was reported by Ladenburg Thalmann on September 22, 2023. The analyst firm set a price target for $3.00 expecting COEP to rise to within 12 months (a possible 219.15% upside). 9 analyst firms have reported ratings in the last year.
拉登堡·塔爾曼於2023年9月22日公佈了Coeptis Therapeutics（納斯達克股票代碼：COEP）的最新目標股價。該分析公司將目標股價設定爲3.00美元，預計COEP將在12個月內上漲至3美元（可能上漲219.15％）。去年有9家分析公司公佈了評級。
What is the most recent analyst rating for Coeptis Therapeutics (COEP)?
Coeptis Therapeutics（COEP）的最新分析師評級是多少？
The latest analyst rating for Coeptis Therapeutics (NASDAQ: COEP) was provided by Ladenburg Thalmann, and Coeptis Therapeutics initiated their buy rating.
Coeptis Therapeutics（納斯達克股票代碼：COEP）的最新分析師評級由拉登堡·塔爾曼提供，Coeptis Therapeutics啓動了買入評級。
When is the next analyst rating going to be posted or updated for Coeptis Therapeutics (COEP)?
Coeptis Therapeutics（COEP）的下一個分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Coeptis Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Coeptis Therapeutics was filed on September 22, 2023 so you should expect the next rating to be made available sometime around September 22, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Coeptis Therapeutics的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Coeptis Therapeutics的最後一次評級是在2023年9月22日公佈的，因此您應該預計下一個評級將在2024年9月22日左右公佈。
Is the Analyst Rating Coeptis Therapeutics (COEP) correct?
分析師對Coeptis Therapeutics（COEP）的評級是否正確？
While ratings are subjective and will change, the latest Coeptis Therapeutics (COEP) rating was a initiated with a price target of $0.00 to $3.00. The current price Coeptis Therapeutics (COEP) is trading at is $0.94, which is within the analyst's predicted range.
儘管評級是主觀的，而且將發生變化，但Coeptis Therapeutics（COEP）的最新評級是啓動的，目標股價爲0.00美元至3.00美元。Coeptis Therapeutics（COEP）目前的交易價格爲0.94美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。